Phoenix Holdings Ltd. Gilead Sciences, Inc. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $1.76 Million - $2.01 Million	-31,114 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $192,385 - $241,891	3,098 Added 11.06%	31,114 $1.82 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $989,249 - $1.15 Million	-13,675 Reduced 32.8%	28,016 $1.99 Million
Q1 2020 May 20, 2020	SELL	$62.63 - $80.22 $8.65 Million - $11.1 Million	-138,162 Reduced 76.82%	41,691 $3.03 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $4.35 Million - $4.78 Million	-70,547 Reduced 28.17%	179,853 $11.6 Million

Q3 2019 Nov 18, 2019	BUY	$62.51 - $69.0 $15.7 Million - $17.3 Million	250,400 New	250,400 $15.1 Million

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.